Publications by authors named "Neil Steven"

Claim this Profile
M
Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19.
Éanna Fennell, Graham S Taylor, Ciara I Leahy, Aisling M Ross, Gary Reynolds, Neil Steven

Eur Respir J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of colitis induced by immune-checkpoint inhibitors therapy in melanoma patients by an overall grading scale.
Trang L Nguyen, Alice Tew, Laura Kirton, Neil Steven

J Oncol Pharm Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study.
Shailender Bhatia, Suzanne L Topalian, William Sharfman, Tim Meyer, Neil Steven

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.
Joseph J Sacco, Richard Jackson, Pippa Corrie, Sarah Danson, T R Jeffry Evans, Neil Steven

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition.
Jarrod J Homer, Stuart C Winter, Elizabeth C Abbey, Hiba Aga, Reshma Agrawal, Neil Steven

J Laryngol Otol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF mutant advanced melanoma (INTERIM).
Alimu Dayimu, Avinash Gupta, Rubeta N Matin, Jenny Nobes, Ruth Board, Neil Steven

Eur J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.
Alice Tew, Leila Khoja, Lalit Pallan, Neil Steven

J Oncol Pharm Pract· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004-2018: a cohort study.
Khaylen Mistry, Nick J Levell, Loes Hollestein, Marlies Wakkee, Tamar Nijsten, Neil M Steven

Br J Dermatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient.
P Kissoonsingh, B Sutton, Syed U Iqbal, Lalit Pallan, Neil Steven

Case Rep Oncol Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity.
Sean Hammond, Anna Olsson-Brown, Sophie Grice, Andrew Gibson, Joshua Gardner, Neil Steven

Toxicol Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.
Paolo Antonio Ascierto, Kristina Orlova, Giovanni Grignani, Monika Dudzisz-Śledź, Eyal Fenig, Neil Steven

Int J Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the role of the surgeon in the management of head and neck mucosal melanoma in the immunotherapy era?
Mark Edmond, Pablo Nenclares, Kevin Harrington, Derfel Ap Dafydd, Izhar Bagwan, Neil Steven

Head Neck· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH).
Jennifer Pascoe, Aimee Jackson, Charlotte Gaskell, Claire Gaunt, Joyce Thompson, Neil Steven

BMC Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.
Stelios Chrysostomou, Rajat Roy, Filippo Prischi, Lucksamon Thamlikitkul, Kathryn L Chapman, Neil M Steven

Sci Transl Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma.
Mark R Middleton, Cheryl McAlpine, Victoria K Woodcock, Pippa Corrie, Jeffrey R Infante, Neil M Steven

Clin Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head and neck mucosal melanoma: The United Kingdom national guidelines.
Pablo Nenclares, Derfel Ap Dafydd, Izhar Bagwan, Donna Begg, Cyrus Kerawala, Neil Steven

Eur J Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of rheumatic complications of immune checkpoint inhibitor therapy - an oncological perspective.
Neil M Steven, Benjamin A Fisher

Rheumatology (Oxford)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report.
Margaret Corrigan, Geoffrey Haydon, Fiona Thompson, Neil Rajoriya, Claire L Peplow, Neil Steven

JHEP Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1-associated inflammatory arthritis.
Mark Ford, Ilfita Sahbudin, Andrew Filer, Neil Steven, Benjamin A Fisher

Rheumatology (Oxford)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steroid refractory dermatomyositis following combination dabrafenib and trametinib therapy.
Stephanie R Harrison, Alice Tew, Neil Steven, Benjamin A Fisher

Rheumatology (Oxford)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seronegative antibody-mediated neurology after immune checkpoint inhibitors.
Robert Wilson, David A Menassa, Alexander J Davies, Sophia Michael, Joanna Hester, Neil Steven

Ann Clin Transl Neurol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.
Teresa M Petrella, Caroline Robert, Erika Richtig, Wilson H Miller, Giuseppe V Masucci, Neil Steven

Eur J Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic vaccination strategies to treat nasopharyngeal carcinoma.
Graham S Taylor, Neil M Steven

Chin Clin Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research methods to change clinical practice for patients with rare cancers.
Lucinda Billingham, Kinga Malottki, Neil Steven

Lancet Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis